Bison Capital Acquisition Corp. Announces Consummation of Over-Allotment Exercise in Connection With Its Initial Public Offering
/
Date05 Jul 2017
NEW YORK and HONG KONG, July 05, 2017 (GLOBE NEWSWIRE) — Bison Capital Acquisition Corp. (Nasdaq:BCACU) (“Bison” or the “Company”), announced today that the underwriters... Read More →
Avenue Therapeutics Completes Initial Public Offering
/
Date30 Jun 2017
NEW YORK, June 30, 2017 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (NASDAQ:ATXI) (“Avenue”), a Fortress Biotech, Inc. (NASDAQ:FBIO) company, announced today that it has completed... Read More →
Tintri, Inc. (Nasdaq: TNTR) to Ring The Nasdaq Stock Market Opening Bell in Celebration of Its IPO
/
Date30 Jun 2017
ADVISORY, June 30, 2017 (GLOBE NEWSWIRE) — What: Tintri, Inc. (Nasdaq:TNTR), a leader in cloud enterprise platform, will visit the Nasdaq MarketSite in Times Square in... Read More →
ShiftPixy Completes its $12,000,000 IPO listing with Nasdaq
/
Date29 Jun 2017
IRVINE, Calif., June 29, 2017 (GLOBE NEWSWIRE) — ShiftPixy, Inc., (NASDAQ:PIXY) (“ShiftPixy”) announced today that it has completed the Company’s initial public offering under the... Read More →
Dova Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
/
Date29 Jun 2017
DURHAM, N.C., June 28, 2017 (GLOBE NEWSWIRE) — Dova Pharmaceuticals, Inc. (NASDAQ:DOVA), a pharmaceutical company focused on acquiring, developing and commercializing drug candidates for rare... Read More →
180 Degree Capital Corp.’s Portfolio Company, Mersana Therapeutics Inc., Completes Initial Public Offering
/
Date28 Jun 2017
MONTCLAIR, N.J., June 28, 2017 (GLOBE NEWSWIRE) — 180 Degree Capital Corp. (“180”) (NASDAQ:TURN) noted today that its portfolio company, Mersana Therapeutics, Inc., completed an... Read More →
Avenue Therapeutics Prices Initial Public Offering of $33,000,000 of Common Stock
/
Date26 Jun 2017
NEW YORK, June 26, 2017 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (“Avenue”), a Fortress Biotech, Inc. (NASDAQ:FBIO) company, announced today the pricing of its initial... Read More →
Bison Capital Acquisition Corp. Completes $52,500,000 Initial Public Offering
/
Date23 Jun 2017
NEW YORK and HONG KONG, June 23, 2017 (GLOBE NEWSWIRE) — Bison Capital Acquisition Corp. (Nasdaq:BCACU) (“Bison” or the “Company”), a company formed for the... Read More →
Spring Bank Pharmaceuticals Prices $37.5 Million Public Offering of Common Stock
/
Date22 Jun 2017
HOPKINTON, Mass., June 22, 2017 (GLOBE NEWSWIRE) — Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH) (“Spring Bank”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment... Read More →
Bison Capital Acquisition Corp. Announces Pricing of $52.5 Million Initial Public Offering
/
Date20 Jun 2017
NEW YORK and HONG KONG, June 19, 2017 (GLOBE NEWSWIRE) — Bison Capital Acquisition Corp. (NASDAQ:BCACU) (the “Company” or “Bison”) announced today that it priced... Read More →